Brian Skorney
Stock Analyst at Robert W. Baird
(0.11)
# 4,648
Out of 4,707 analysts
844
Total ratings
36.4%
Success rate
-5.8%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Maintained: Buy | $25 | $15.90 | +57.23% | 1 | Sep 3, 2026 | |
| ALMS Alumis | Maintained: Buy | $17 → $27 | $10.58 | +155.20% | 4 | Sep 1, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $32 → $29 | $8.76 | +231.05% | 19 | Aug 25, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $400 → $514 | $352.48 | +45.82% | 4 | Aug 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $129 → $123 | $99.53 | +23.58% | 44 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Sell | $215 → $230 | $393.17 | -41.50% | 52 | Aug 5, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $252 → $280 | $240.07 | +16.63% | 3 | Aug 4, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $186 → $225 | $155.13 | +45.04% | 53 | Jul 31, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $742 → $761 | $810.31 | -6.09% | 64 | Jul 31, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Sell | $320 → $350 | $528.90 | -33.82% | 59 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $36 | $35.81 | +0.53% | 15 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $241 → $246 | $207.82 | +18.37% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $97 | $59.55 | +62.89% | 6 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $20 | $20.94 | -4.49% | 108 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $145 | $146.64 | -1.12% | 81 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $250 | $212.50 | +17.65% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $52 | $14.72 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $32 | $20.31 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.73 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $13.50 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $4.76 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $5.18 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $26.13 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $3.40 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $0.2434 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $30.00 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $17.06 | n/a | 24 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $39.57 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $35.28 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $11.69 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.82 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $3.16 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 → $146 | $12.74 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.40 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $1.27 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $56.60 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $351.48 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $124.89 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $64.63 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $21.34 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.37 | n/a | 3 | Jan 22, 2015 |
Climb Bio
Sep 3, 2026
Maintained: Buy
Price Target: $25
Current: $15.90
Upside: +57.23%
Alumis
Sep 1, 2026
Maintained: Buy
Price Target: $17 → $27
Current: $10.58
Upside: +155.20%
REGENXBIO
Aug 25, 2026
Maintained: Buy
Price Target: $32 → $29
Current: $8.76
Upside: +231.05%
Praxis Precision Medicines
Aug 7, 2026
Maintained: Buy
Price Target: $400 → $514
Current: $352.48
Upside: +45.82%
Mirum Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $129 → $123
Current: $99.53
Upside: +23.58%
Amgen
Aug 5, 2026
Maintained: Sell
Price Target: $215 → $230
Current: $393.17
Upside: -41.50%
Jazz Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $252 → $280
Current: $240.07
Upside: +16.63%
Neurocrine Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $186 → $225
Current: $155.13
Upside: +45.04%
Regeneron Pharmaceuticals
Jul 31, 2026
Maintained: Hold
Price Target: $742 → $761
Current: $810.31
Upside: -6.09%
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Sell
Price Target: $320 → $350
Current: $528.90
Upside: -33.82%
May 18, 2026
Maintained: Buy
Price Target: $38 → $36
Current: $35.81
Upside: +0.53%
May 5, 2026
Maintained: Buy
Price Target: $241 → $246
Current: $207.82
Upside: +18.37%
Mar 9, 2026
Maintained: Buy
Price Target: $63 → $97
Current: $59.55
Upside: +62.89%
Feb 26, 2026
Maintained: Hold
Price Target: $22 → $20
Current: $20.94
Upside: -4.49%
Feb 11, 2026
Maintained: Hold
Price Target: $108 → $145
Current: $146.64
Upside: -1.12%
Oct 31, 2025
Maintained: Buy
Price Target: $255 → $250
Current: $212.50
Upside: +17.65%
Aug 12, 2025
Maintained: Buy
Price Target: $57 → $52
Current: $14.72
Upside: n/a
Jun 18, 2025
Maintained: Buy
Price Target: $46 → $32
Current: $20.31
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $12.73
Upside: n/a
Nov 26, 2024
Maintained: Buy
Price Target: $26 → $20
Current: $13.50
Upside: n/a
Nov 20, 2024
Maintained: Buy
Price Target: $28
Current: $4.76
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: $4
Current: $5.18
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $26.13
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $3.40
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $7.5
Current: $0.2434
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $28
Current: $30.00
Upside: n/a
Nov 7, 2022
Maintained: Hold
Price Target: $8
Current: $17.06
Upside: n/a
Sep 8, 2022
Maintained: Hold
Price Target: $6
Current: $39.57
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $15
Current: $35.28
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $16
Current: $11.69
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $7.82
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $3.16
Upside: n/a
Aug 5, 2021
Maintained: Hold
Price Target: $85 → $146
Current: $12.74
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: $6
Current: $3.40
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $7 → $3
Current: $1.27
Upside: n/a
Mar 27, 2018
Maintained: Buy
Price Target: $144
Current: $56.60
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $351.48
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $124.89
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $64.63
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $21.34
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $4.37
Upside: n/a